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Abstract
Background: The challenges of today’s society call for more knowledge about how to maintain all aspects of
cognitive health, such as speed/attention, memory/learning, visuospatial ability, language, executive capacity and
social cognition during the life course.
Main text: Medical advances have improved treatments of numerous diseases, but the cognitive implications have
not been sufficiently addressed. Disability induced by cognitive dysfunction is also a major issue in groups of patients
not suffering from Alzheimer’s disease or related disorders. Recent studies indicate that several negative lifestyle factors
can contribute to the development of cognitive impairment, but intervention and prevention strategies have not been
implemented. Disability due to cognitive failure among the workforce has become a major challenge. Globally, the
changing aging pyramid results in increased prevalence of cognitive disorders, and the diversity of cultures influences
the expression, manifestation and consequences of cognitive dysfunction.
Conclusions: Major tasks in the field of cognitive medicine are basic neuroscience research to uncover diverse disease
mechanisms, determinations of the prevalence of cognitive dysfunction, health-economical evaluations, and
intervention studies. Raising awareness for cognitive medicine as a clinical topic would also highlight the importance
of specialized health care units for an integrative approach to the treatment of cognitive dysfunctions.
Keywords: Neurocognitive disorders, Classification of diseases, Disability, Rehabilitation, Mental functions, Learning and
memory, Executive control, Societal challenge, Stress and environment
Background
Cognitive medicine – an emerging field
Cognition is a summary term for thought processes used
in interactions with other humans and the environment
and is often described as a system of cognitive functions
ranging from visual perception to social cognition [1]. A
longer work life and the need for skill development due
to rapid technological development and global competi-
tion have led to increased demands on the individual to
sustain a high cognitive performance. Medical advances
have been rapid, but the cognitive implications of
various diseases have not been sufficiently addressed.
Furthermore, a growing number of elderly combined
with changed lifestyle have resulted in many health-
related consequences, including disability due to cognitive
impairment. Thus, a major challenge for today’s society is
to maintain cognitive health in order to avoid disability.
Cognitive impairment or decline is part of the essential
symptomatology in a wide spectrum of medical condi-
tions over the life course, including diseases that are not
primarily associated with cognitive deficits, such as heart
insufficiency, infections and cancer. In this paper, we
argue for the need to develop the concept of cognitive
medicine as an umbrella term covering aspects of cogni-
tion across different health conditions and diseases, to
merge and increase knowledge of how to prevent, diag-
nose, cope and intervene with cognitive decline (Fig. 1).
We define cognitive medicine as a field of knowledge
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prevention, study and treatment of cognitive impairment
and decline.
Major research tasks in cognitive medicine are to
uncover cellular and molecular mechanisms underlying
decline of cognitive functions, to determine the prevalence
and incidence of cognitive dysfunctions in epidemiological
populations and patient populations, health-economical
evaluations of cognitive impairments, and intervention
studies to investigate the effects of medical treatments and
lifestyle interventions. Furthermore, new tools need to be
developed such as high- and low-tech diagnostic proce-
dures for cognitive profiling, imaging, biochemistry and
genetics. The knowledge from cognitive medicine will also
be useful to clarify the role of the current memory clinics,
to form health care units for patients with diseases associ-
ated with cognitive decline and to implement education
programs for a medical specialty in cognitive medicine.
Main text
Cognitive functions throughout the life course
The cognitive system is usually believed to comprise six
key functions, which in turn are divided in subdomains
[1]. The key cognitive functions are perceptual-motor
function (including visuospatial function), attention,
learning and memory, language, executive function and
social cognition. There is no clear-cut border between
cognitive, emotional and volitional functions as cogni-
tion comprises a volitional component and influences
emotional reactions and decision-making. When the
information process takes place, it engages the cognitive
functions in a specific order. Information obtained by
the sensory systems is selected for further processing
with the aid of attention. The selected information can
then be retained over shorter time periods by a working-
memory system. Broadly defined, executive functions
include initiation, motivation, planning, and control of
goal-oriented basic and complex actions, and incorpor-
ate more basic executive processes such as shifting,
updating, and inhibition. Various long-term memory
systems allow information to be retained over weeks,
months, and even years. Memory systems are specialized
for different types of information (facts, events and
procedures). Semantic memory, the long-term memory
for facts, is closely related to language functions.
Language, i.e. symbolic representation according to set
rules, and visuospatial functions, i.e. comprehending and
conceptualizing visual representations and spatial rela-
tionships, are used in certain contexts. Social cognition
is a set of complex cognitive processes centered on
social interactions, such as understanding other persons’
wishes and needs. Related to social cognition is metacog-
nition, which refers to the ability to reflect upon one’s
own cognitive processes.
Most cognitive capacities develop from infancy
through childhood and adolescence into adulthood and
reflect the maturation of the central nervous system over
time. By 10 years of age, when the brain has begun to
reach its adult size, children have already undergone
substantial development in cognitive functions [2, 3].
Cognition continues to develop in parallel with a refine-
ment of neural networks via synaptic strengthening and
pruning as well as myelination. In aging, many but not
all cognitive functions begin to decline. Examples of
cognitive functions that are well-preserved into older
age include memory for facts, social cognition, and more
general functions that tap into well-consolidated infor-
mation [4]. Age-sensitive cognitive functions include
working memory, certain forms of attentional functions,
episodic long-term memory, and several executive
functions. The normal variation in cognitive capacity
between individuals increases with age, and while some
older adults show marked cognitive decline other
maintain high levels of cognitive functioning [5].
Disability
An independent and productive life requires that cognitive
functions are preserved or compensated for, otherwise
disability will arise. The World Health Organization
Fig. 1 Cognitive medicine is an emerging topic dealing with cognitive
impairment during the life course in medical and associated contexts
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(WHO) has defined disability as an umbrella term cover-
ing impairments, activity limitations, and restrictions in
participation [6]. An impairment is a problem in body
function or structure; an activity limitation is a difficulty
encountered by an individual in executing a task or action;
while a participation restriction is a problem experienced
by an individual in involvement in life situations. There-
fore, disability cannot be seen as just a health problem but
as a phenomenon, which is reflecting the interaction
between features of a person’s body and features of the
society in which he or she lives. In the “World Report of
Disability “from WHO and the World Bank it is shown
that not only are persons with disability at an economic
disadvantage caused by difficulties in getting/keeping a job.
There is also the burden on the family, where family
members often have to stay at home to take care of the
disabled person [7].
Since impairment of cognitive functions always has an
impact on various types of human activities, cognitive
impairments are unambiguously linked to disability. The
consequences of the impaired cognition depend on the
activities required as well as the environment these will
occur in and both relate to the societal circumstances a
person may encounter. Examples of activities that can be
affected include planning daily actions, accomplishing
tasks in working life, handling stress, managing personal
economic matters, communicating with others and par-
ticipating in leisure activities. For example, both stroke
and schizophrenia conditions might affect cognition but
the consequences can be different depending on other
impairments as well as environmental and personal
factors [8–10]. Here, the continuing development of
tools, as well as restorative and compensatory measures
are of great importance.
Basic research perspective
There are several disorders that give rise to cognitive
dysfunctions such as early-life neuropsychiatric disor-
ders, trauma, epilepsy, Alzheimer’s disease, Parkinson’s
disease and other neurological disorders, bipolar disor-
ders, substance abuse and other psychiatric disorders,
infectious and inflammatory diseases, stroke and other
vascular disorders, cancer and endocrine diseases. The
idea of cognitive medicine is to integrate research on be-
havioral, cellular and molecular mechanisms associated
with cognitive dysfunctions in divers disorders.
Although Alzheimer’s disease is the most studied cogni-
tive disorder, the key pathobiological events in the early
phases of the disease have not yet been clearly defined.
There are indications that the onset of the pathological
events in Alzheimer’s disease might occur already two
decades before cognitive impairment is debilitating [11].
Therefore, early symptoms of Alzheimer’s disease could
coincide with work life-related cognitive alterations and
psychiatric conditions such as anxiety, depression and
stress-related exhaustion. Furthermore, an important focus
of cognitive medicine is to investigate whether cognitive
disorders late in life are associated with, or even casually
linked to, lifestyle-related diseases earlier in life such as
hypertension, diabetes, and obesity.
There is overlap in pathology between Alzheimer’s
disease and other cognitive disorders such as vascular
cognitive impairment [12, 13], and the affected pathways
can be detected using cognitive profiling. Alzheimer’s
disease, also early in the course of the disease, is charac-
terized by memory loss and difficulties in interpreting
sensory information. In contrast, subcortical small vessel
disease displays a cognitive pattern of early dysfunction
of mental speed and executive capacity [14, 15]. Cogni-
tive assessment can be used to distinguish Alzheimer’s
disease from other dementing disorders such as subcor-
tical small vessel disease and also to evaluate to what ex-
tent there is co-existence of the conditions.
Prevalence of cognitive dysfunction and health economy
WHO estimated that 47 million people have advanced
cognitive impairment worldwide, and the estimation is
that this will increase to near 75 million in 2030 and to
132 million in 2050. According to estimations by the
Alzheimer’s Association, 15-20% of individuals aged 65
and above suffers from mild cognitive impairment. How-
ever, different studies have shown highly variable results
depending on the cohort studied and the cognitive tests
used. A major task for researchers working in the field
of cognitive medicine is therefore to determine, in
population-based as well as patient cohort studies, the
prevalence of cognitive functions in work life, education,
rehabilitation, and chronic diseases. For this purpose,
the development of new, standardized tools to measure
cognitive functions in large cohorts is needed. Based on
the prevalence and incidence of cognitive dysfunctions
and the degrees of disability, health economic calcula-
tions can be performed to determine focus area of spe-
cific interest for cognitive medicine and to facilitate
health care planning.
Working life perspective
Cognitive dysfunctions during work life is one focus area
in cognitive medicine. In today’s society, the rapid devel-
opment in information technology, social media, and
transmission of information continually changes life
conditions. Adaptation to the changing cognitive de-
mands is crucial and cognitive flexibility, which is a
component of executive function, has become ever more
important. Reduced working performance due to a mis-
match between the cognitive demands and cognitive
function is a growing challenge for many workplaces.
We are just beginning to understand the cognitive
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impairments that are associated with work-related stress
and how to prevent and treat these deficiencies. Moreover,
medical professionals from occupational and insurance
medicine among others are in need of novel tools for evalu-
ating the relationship between cognitive functions, working
capacity and medical symptoms for the assessment of cogni-
tive impairments in different patient groups, objectives that
teams of cognitive medicine specialists could accomplish.
Global perspective
The rapid increase in the prevalence of advanced cognitive
impairment is a global issue since the number of elderly
individuals increases also in developing countries with
rapid population growth, which will result in a marked rise
in the prevalence of age-related brain diseases [16]. In
addition, environmental aspects have attracted a higher
level of attention as life-long exposure to infectious agents
and environmental toxins may increase the risk for
cognitive impairment [17, 18]. In developing countries,
urbanization and increased psychosocial demands in work-
ing life will not only influence cognitive health in the
elderly but also in young and middle-aged people. More-
over, a major challenge from a medical perspective is the
contextual aspect of cognitive performance. This means
that the diversity of cultures worldwide influences the
expression, manifestation and consequences of cognitive
dysfunction, implying that a socio-cultural approach,
besides medical and psychological advances, is needed.
Prevention and intervention
There are at present few effective medical treatments for
cognitive disorders. Obviously, randomized clinical trials
for new treatments affecting the underlying pathological
mechanisms are needed. Another aspect is that negative
lifestyle factors contribute substantially to the develop-
ment of cognitive impairments [19], but successful
lifestyle-related prevention and intervention strategies
have yet to be implemented. In our aging population
with increased stress-related disorders and sedentary
lifestyle, cognitive impairments as a cause of disability
has risen to epidemic proportions globally. A major
question that has to be addressed by cognitive medicine
is whether cognitive decline, seemingly due to prevent-
able lifestyle factors, is partly or fully reversible if
adequate treatment is given.
A sedentary lifestyle is not only of importance during
adulthood or aging. There is clear evidence that lack of
exercise and obesity correlate with lower cognitive
performance both at school age in school, as well as later
in life [20–22]. Large longitudinal cohort studies have indi-
cated increased risk for psychiatric diseases, such as
depression and anxiety disorders, and brain diseases, such
as stroke and major neurocognitive disorders, later in life
in subjects with low physical performance during late
adolescence [23–25]. In light of the epidemic development
of obesity and physical inactivity worldwide, research in
cognitive medicine will also address how to design success-
ful early prevention and interventions in children and
adults in order to develop and maintain an active lifestyle
thereby increasing resilience against cognitive dysfunctions
throughout the life course.
Integration with existing medical care practice
Memory clinics or similar health care units deal mainly
with Alzheimer’s disease and related neurocognitive disor-
ders. The responsibilities of such units may be expanded
to also include investigation of various disorders usually
not classified as classical memory disorders, but which
may exhibit cognitive dysfunctions as essential component
that worsen rehabilitation and prevent return to work.
The overall aim of such health care units, in addition its
traditional task, would be to identify and evaluate severity,
profile and consequences of cognitive impairments for
treatment of the somatic and psychiatric disorders.
Furthermore, competence in cognitive medicine can be
increased by introducing 6-12 months practice at these
units for doctors trained in neurology, psychiatry, rehabili-
tation medicine or general practice. Nurses and psycholo-
gists can increase their competence in cognitive medicine
in a similar way.
Conclusions
Cognitive medicine is aiming at creating specific know-
ledge about the relationships between disease processes,
cognitive functions and disabilities. There is a need to
establish new tools for identification of cognitive impair-
ments in various medical conditions. Without such cog-
nitive assessment instruments taking into account the
whole spectrum of cognitive functions, it will be difficult
to interpret genetic, biochemical, and imaging data both
in research and clinical practice. In addition, the highly
technological approach using fluid and imaging
biomarkers is not available in all contexts and countries,
which means that precise and standardized cognitive
assessment may be the only way of getting information
about the suspected cognitive disorder. Based on our
argumentation, we recommend that cognitive medicine
becomes a recognizable field in healthcare, education
and research programs.
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